hrp0086fc1.5 | Adrenals | ESPE2016

AAV Gene Therapy of 21-Hydroxylase Deficiency (21OHD) in Cyp21−/− mice

Perdomini Morgane , Santos Christine Menguy-Dos , Goumeaux Cyndie , Guidoux Sylvie , Pourcher Guillaume , Aubourg Patrick , Bougneres Pierre

Background: Despite current treatment, girls and women with severe forms of 21OHD are exposed lifelong to a chronic excess of androgens and the secondary effects of suppressive corticoids, which make gene therapy (GT) an option to be explored.Objective: To evaluate the effect of human CYP21 gene transfer mediated by adeno-associated virus (AAV) in a Cyp21−/− mouse model.Methods: 17 adult <em...